Jonathan Newman

15.5k total citations · 1 hit paper
114 papers, 3.9k citations indexed

About

Jonathan Newman is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jonathan Newman has authored 114 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Cardiology and Cardiovascular Medicine, 24 papers in Surgery and 17 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jonathan Newman's work include Blood Pressure and Hypertension Studies (16 papers), Animal Vocal Communication and Behavior (12 papers) and Diabetes Treatment and Management (10 papers). Jonathan Newman is often cited by papers focused on Blood Pressure and Hypertension Studies (16 papers), Animal Vocal Communication and Behavior (12 papers) and Diabetes Treatment and Management (10 papers). Jonathan Newman collaborates with scholars based in United States, Canada and United Kingdom. Jonathan Newman's co-authors include Jeffrey S. Berger, Judith S. Hochman, Daichi Shimbo, Arthur Schwartzbard, Sripal Bangalore, Stuart D. Katz, Harmony R. Reynolds, George D. Thurston, Yu Chen and Michael E. Farkouh and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Jonathan Newman

107 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19

2020 744 citations Jonathan Newman, Jeffrey S. Berger et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan Newman United States	30	1.2k	670	575	518	435	114	3.9k
Roberto Manfredini Italy	44	2.0k 1.6×	207 0.3×	335 0.6×	1.3k 2.5×	1.1k 2.6×	322	6.9k
Lin Xu China	38	684 0.6×	1.2k 1.8×	1.0k 1.8×	642 1.2×	295 0.7×	368	7.4k
Amelia K. Boehme United States	38	741 0.6×	495 0.7×	112 0.2×	376 0.7×	419 1.0×	213	5.5k
Cristoforo Pomara Italy	38	525 0.4×	342 0.5×	481 0.8×	321 0.6×	122 0.3×	143	3.9k
Dwayne Reed United States	51	1.7k 1.4×	246 0.4×	1.3k 2.3×	1.1k 2.2×	217 0.5×	118	7.9k
Isabelle Carrière France	43	511 0.4×	152 0.2×	526 0.9×	265 0.5×	247 0.6×	135	5.6k
Anna Vittoria Mattioli Italy	31	1.4k 1.2×	153 0.2×	118 0.2×	395 0.8×	93 0.2×	209	3.5k
Francesco Sessa Italy	33	489 0.4×	408 0.6×	347 0.6×	250 0.5×	57 0.1×	135	3.0k
Chun Soo Lim South Korea	39	662 0.6×	111 0.2×	409 0.7×	698 1.3×	193 0.4×	251	5.4k
Leena Choi United States	31	550 0.5×	311 0.5×	247 0.4×	520 1.0×	91 0.2×	124	4.7k

Countries citing papers authored by Jonathan Newman

Since Specialization

Citations

This map shows the geographic impact of Jonathan Newman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Newman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Newman more than expected).

Fields of papers citing papers by Jonathan Newman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Newman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Newman. The network helps show where Jonathan Newman may publish in the future.

Co-authorship network of co-authors of Jonathan Newman

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Newman. A scholar is included among the top collaborators of Jonathan Newman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Newman. Jonathan Newman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kundu, Suman, Daniel G. Clair, Aaron W. Aday, et al.. (2025). Association of Lipoprotein(a) With Major Adverse Limb Events and All‐Cause Mortality Following Revascularization for Chronic Limb‐Threatening Ischemia: A Substudy of the BEST‐CLI Trial. Journal of the American Heart Association. 14(11). e041177–e041177.

Boffa, Michael B., Judy Zhong, Michael Garshick, et al.. (2024). Variation in lipoprotein(a) response to potent lipid lowering: The role of apolipoprotein (a) isoform size. Journal of clinical lipidology. 19(1). 39–50. 1 indexed citations

Berger, Jeffrey S., MacIntosh Cornwell, Yuhe Xia, et al.. (2024). A Platelet Reactivity ExpreSsion Score derived from patients with peripheral artery disease predicts cardiovascular risk. Nature Communications. 15(1). 6902–6902. 11 indexed citations

Arnold, Suzanne V., Kensey Gosch, Mikhail Kosiborod, et al.. (2023). Contemporary use of cardiovascular risk reduction strategies in type 2 diabetes. Insights from the diabetes collaborative registry. American Heart Journal. 263. 104–111. 7 indexed citations

Barrett, Tessa J., MacIntosh Cornwell, Yuhe Xia, et al.. (2023). Abstract 292: Platelet Hyperreactivity Characterization by Aggregation and RNA-seq Informs Cardiovascular Risk. Arteriosclerosis Thrombosis and Vascular Biology. 43(Suppl_1).

Neves, João Sérgio, Connie B. Newman, John Bostrom, et al.. (2022). Management of dyslipidemia and atherosclerotic cardiovascular risk in prediabetes. Diabetes Research and Clinical Practice. 190. 109980–109980. 40 indexed citations

Newman, Jonathan, Sanjay Rajagopalan, Phillip D. Levy, & Robert D. Brook. (2020). Clearing the air to treat hypertension. Journal of Human Hypertension. 34(11). 759–763. 8 indexed citations

Block, Christophe De, et al.. (2020). Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists. Journal of the American College of Cardiology. 75(16). 1956–1974. 62 indexed citations

Mechanick, Jeffrey I., Michael E. Farkouh, Jonathan Newman, & W. Timothy Garvey. (2020). Cardiometabolic-Based Chronic Disease, Addressing Knowledge and Clinical Practice Gaps. Journal of the American College of Cardiology. 75(5). 539–555. 56 indexed citations

10.

Newman, Jonathan, et al.. (2018). The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction. Journal of the American College of Cardiology. 72(15). 1856–1869. 65 indexed citations

11.

Moon, Katherine, Ana Navas‐Acién, María Grau-Pérez, et al.. (2017). Low-moderate urine arsenic and biomarkers of thrombosis and inflammation in the Strong Heart Study. PLoS ONE. 12(8). e0182435–e0182435. 15 indexed citations

12.

Newman, Jonathan, Christina Echagarruga, Emilie Montenont, et al.. (2017). Hyperglycemia enhances arsenic-induced platelet and megakaryocyte activation. Journal of Translational Medicine. 15(1). 55–55. 8 indexed citations

13.

Shah, Binita, James Slater, Jonathan Newman, et al.. (2017). The effect of a vegan versus AHA DiEt in coronary artery disease (EVADE CAD) trial: Study design and rationale. Contemporary Clinical Trials Communications. 8. 90–98. 7 indexed citations

14.

Mathew, Roy O., Joshua Schulman‐Marcus, Elizabeth L. Nichols, et al.. (2017). Chelation Therapy as a Cardiovascular Therapeutic Strategy: the Rationale and the Data in Review. Cardiovascular Drugs and Therapy. 31(5-6). 619–625. 9 indexed citations

15.

Shimbo, Daichi, Lu Wang, Michael J. LaMonte, et al.. (2014). The effect of hormone therapy on mean blood pressure and visit-to-visit blood pressure variability in postmenopausal women. Journal of Hypertension. 32(10). 2071–2081. 22 indexed citations

16.

Larson, Joseph C., Mina K. Chung, Anne B. Curtis, et al.. (2013). Does CHA2DS2-VASc Improve Stroke Risk Stratification in Postmenopausal Women with Atrial Fibrillation?. The American Journal of Medicine. 126(12). 1143.e1–1143.e8. 14 indexed citations

17.

Edmondson, Donald, Jonathan Newman, Melinda J. Chang, Peter Wyer, & Karina W. Davidson. (2012). Depression is associated with longer emergency department length of stay in acute coronary syndrome patients. BMC Emergency Medicine. 12(1). 14–14. 8 indexed citations

18.

Newman, Jonathan, Karina W. Davidson, Jonathan A. Shaffer, et al.. (2011). Observed Hostility and the Risk of Incident Ischemic Heart Disease. Journal of the American College of Cardiology. 58(12). 1222–1228. 20 indexed citations

19.

Boinski, Sue & Jonathan Newman. (1988). Preliminary observations on squirrel monkey (Saimiri oerstedi) vocalizations in Costa Rica. American Journal of Primatology. 14(4). 329–343. 21 indexed citations

20.

Arnold, William H., Stuart W. Bowen, David L. Kaplan, et al.. (1979). Mass Drivers III: Engineering. NASA Special Publication. 428. 119. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact